These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The accuracy of flow cytometric cell-based assay to detect anti-myelin oligodendrocyte glycoprotein (MOG) antibodies determining the optimal method for positivity judgement. Sugimoto K; Mori M; Liu J; Tanaka S; Kaneko K; Oji S; Takahashi T; Uzawa A; Uchida T; Masuda H; Ohtani R; Nomura K; Hiwasa T; Kuwabara S J Neuroimmunol; 2019 Nov; 336():577021. PubMed ID: 31473520 [TBL] [Abstract][Full Text] [Related]
8. Diagnosis of multiple sclerosis in times of MOG and AQP4 autoantibody testing - A monocentric study. Weber J; Bernsdorff N; Robinson T; Endres D; Rauer S; Berger B J Neurol Sci; 2021 Feb; 421():117289. PubMed ID: 33360733 [TBL] [Abstract][Full Text] [Related]
9. Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases. Mariotto S; Gajofatto A; Batzu L; Delogu R; Sechi G; Leoni S; Pirastru MI; Bonetti B; Zanoni M; Alberti D; Schanda K; Monaco S; Reindl M; Ferrari S Neurology; 2019 Nov; 93(20):e1867-e1872. PubMed ID: 31645473 [TBL] [Abstract][Full Text] [Related]
10. Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica. Rostásy K; Mader S; Hennes EM; Schanda K; Gredler V; Guenther A; Blaschek A; Korenke C; Pritsch M; Pohl D; Maier O; Kuchukhidze G; Brunner-Krainz M; Berger T; Reindl M Mult Scler; 2013 Jul; 19(8):1052-9. PubMed ID: 23257621 [TBL] [Abstract][Full Text] [Related]
11. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorders: Toward a New Spectrum of Inflammatory Demyelinating CNS Disorders? Di Pauli F; Berger T Front Immunol; 2018; 9():2753. PubMed ID: 30555462 [TBL] [Abstract][Full Text] [Related]
12. Detection of MOG-IgG in Clinical Samples by Live Cell-Based Assays: Performance of Immunofluorescence Microscopy and Flow Cytometry. Marchionatti A; Hansel G; Avila GU; Sato DK Front Immunol; 2021; 12():642272. PubMed ID: 34025652 [TBL] [Abstract][Full Text] [Related]
13. Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands. van Pelt ED; Wong YY; Ketelslegers IA; Hamann D; Hintzen RQ Eur J Neurol; 2016 Mar; 23(3):580-7. PubMed ID: 26593750 [TBL] [Abstract][Full Text] [Related]
14. Clinical Characteristics and Treatment of MOG-IgG-Associated Optic Neuritis. Tajfirouz DA; Bhatti MT; Chen JJ Curr Neurol Neurosci Rep; 2019 Nov; 19(12):100. PubMed ID: 31773369 [TBL] [Abstract][Full Text] [Related]
18. Refining cell-based assay to detect MOG-IgG in patients with central nervous system inflammatory diseases. Kim Y; Hyun JW; Woodhall MR; Oh YM; Lee JE; Jung JY; Kim SY; Lee MY; Kim SH; Kim W; Irani SR; Waters P; Choi K; Kim HJ Mult Scler Relat Disord; 2020 May; 40():101939. PubMed ID: 31978673 [TBL] [Abstract][Full Text] [Related]
19. Detection of Autoantibodies Against Myelin Oligodendrocyte Glycoprotein in Multiple Sclerosis and Related Diseases. Spadaro M; Meinl E Methods Mol Biol; 2016; 1304():99-104. PubMed ID: 25814289 [TBL] [Abstract][Full Text] [Related]
20. Clinical and neuroimaging characteristics of MOG autoimmunity in children with acquired demyelinating syndromes. Ferilli MAN; Valeriani M; Papi C; Papetti L; Ruscitto C; Figà Talamanca L; Ursitti F; Moavero R; Vigevano F; Iorio R Mult Scler Relat Disord; 2021 May; 50():102837. PubMed ID: 33636614 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]